In line with this, several pre-clinical as well as clinical studies demonstrated feasibility of imaging and/or treatment of BC with GRPR and SSTR2 radioligands with promising results, and indicated specific BC patients groups that can benefit from the application of these radioligands [6–10]. This evidence concerns the gene SSTR2 and breast cancer.